siRNA treatment lowers triglycerides in people along with uncommon ailment

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran decreased triglyceride levels by 80% as well as decreased the risk of pancreatitis in individuals along with chronic chylomicronemia, along with or without a hereditary medical diagnosis.